Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases

This publication has 27 references indexed in Scilit:

• The Prognostic Significance of ‘Stage, Tumor Size, Cellular Atypia and DNA Ploidy in Uterine Leiomyosarcoma
  Acta Oncologica, 1995
• Problematic Uterine Smooth Muscle Neoplasms
  The American Journal of Surgical Pathology, 1994
• The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis
  British Journal of Cancer, 1994
• WAF1, a potential mediator of p53 tumor suppression
  Cell, 1993
• Mapping of the p53 and mdm-2 interaction domains.
  Molecular and Cellular Biology, 1993
• p53, guardian of the genome
  Nature, 1992
• Flow cytometric analysis of uterine sarcoma: Ploidy and S-phase rate as prognostic indicators
  Gynecologic Oncology, 1992
• Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors
  Cancer, 1990
• Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: An important prognostic indicator
  Gynecologic Oncology, 1989
• Prognostic impact of ploidy level in carcinoma of the cervix
  American Journal of Clinical Oncology, 1984